Dániel Erös

643 total citations
18 papers, 426 citations indexed

About

Dániel Erös is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Dániel Erös has authored 18 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 5 papers in Oncology. Recurrent topics in Dániel Erös's work include Computational Drug Discovery Methods (8 papers), HER2/EGFR in Cancer Research (4 papers) and Synthesis and biological activity (2 papers). Dániel Erös is often cited by papers focused on Computational Drug Discovery Methods (8 papers), HER2/EGFR in Cancer Research (4 papers) and Synthesis and biological activity (2 papers). Dániel Erös collaborates with scholars based in Hungary, Germany and France. Dániel Erös's co-authors include László Őrfi, Gÿorgý Kéri, István Kövesdi, Ferenc Hollósy, Miklós Idei, Csaba Szántai-Kis, Krisztina Takács‐Novák, Tamás Lóránd, Róbert Kiss and Béla Noszál and has published in prestigious journals such as European Journal of Medicinal Chemistry, Current Medicinal Chemistry and Oncotarget.

In The Last Decade

Dániel Erös

18 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dániel Erös Hungary 13 214 128 116 60 59 18 426
Ákos Tarcsay Hungary 11 282 1.3× 123 1.0× 244 2.1× 56 0.9× 33 0.6× 16 521
Ky-Youb Nam South Korea 11 205 1.0× 117 0.9× 59 0.5× 27 0.5× 40 0.7× 19 569
Hayarpi Torosyan United States 9 350 1.6× 104 0.8× 215 1.9× 35 0.6× 36 0.6× 11 576
Inge Thøger Christensen Denmark 15 328 1.5× 98 0.8× 179 1.5× 93 1.6× 27 0.5× 18 603
Laura Maccari Italy 16 337 1.6× 225 1.8× 117 1.0× 39 0.7× 33 0.6× 24 662
Hitomi Yuki Japan 15 299 1.4× 102 0.8× 252 2.2× 50 0.8× 21 0.4× 29 565
Narayanan Surendran United States 12 146 0.7× 54 0.4× 82 0.7× 53 0.9× 29 0.5× 22 462
Andy Vinter United Kingdom 5 233 1.1× 105 0.8× 155 1.3× 20 0.3× 40 0.7× 7 444
Alessandro Padova Italy 13 335 1.6× 161 1.3× 179 1.5× 23 0.4× 21 0.4× 22 529
Kenneth A. Koeplinger United States 16 523 2.4× 117 0.9× 78 0.7× 83 1.4× 25 0.4× 23 733

Countries citing papers authored by Dániel Erös

Since Specialization
Citations

This map shows the geographic impact of Dániel Erös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dániel Erös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dániel Erös more than expected).

Fields of papers citing papers by Dániel Erös

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dániel Erös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dániel Erös. The network helps show where Dániel Erös may publish in the future.

Co-authorship network of co-authors of Dániel Erös

This figure shows the co-authorship network connecting the top 25 collaborators of Dániel Erös. A scholar is included among the top collaborators of Dániel Erös based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dániel Erös. Dániel Erös is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dobos, Judit, Dániel Erös, Csaba Szántai-Kis, et al.. (2019). Targeted drug combination therapy design based on driver genes. Oncotarget. 10(51). 5255–5266. 12 indexed citations
2.
Herczenik, Eszter, Zoltán Varga, Dániel Erös, et al.. (2009). Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors. Journal of Receptors and Signal Transduction. 29(2). 75–83. 1 indexed citations
3.
Erös, Dániel, et al.. (2009). Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.. PubMed. 11(3). 308–21. 17 indexed citations
4.
5.
Székely, Rita, István Szabadkai, Gábor Németh, et al.. (2008). A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling. Immunology Letters. 116(2). 225–231. 62 indexed citations
6.
Erös, Dániel, et al.. (2008). Structure – Activity Relationships of PDE5 Inhibitors (Supporting Material). Current Medicinal Chemistry. 15(16). 1570–1585. 13 indexed citations
7.
Garai, János, Valéria Molnár, Dániel Erös, László Őrfi, & Tamás Lóránd. (2007). MIF tautomerase inhibitor potency of α,β-unsaturated cyclic ketones. International Immunopharmacology. 7(13). 1741–1746. 5 indexed citations
8.
Kiss, Róbert, et al.. (2007). Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor. European Journal of Medicinal Chemistry. 43(5). 1059–1070. 42 indexed citations
9.
Szántai-Kis, Csaba, István Kövesdi, Dániel Erös, et al.. (2006). Prediction Oriented QSAR Modelling of EGFR Inhibition. Current Medicinal Chemistry. 13(3). 277–287. 11 indexed citations
10.
Kéri, Gÿorgý, László Őrfi, Dániel Erös, et al.. (2006). Signal Transduction Therapy with Rationally Designed Kinase Inhibitors. Current Signal Transduction Therapy. 1(1). 67–95. 34 indexed citations
11.
Ősz, Erzsébet, Ferenc Hollósy, Richárd Schwab, et al.. (2005). Characterization of lipophilicity and antiproliferative activity of E-2-arylmethylene-1-tetralones and their heteroanalogues. Journal of Chromatography B. 819(2). 283–291. 23 indexed citations
12.
Erös, Dániel, Gÿorgý Kéri, István Kövesdi, et al.. (2004). Comparison of Predictive Ability of Water Solubility QSPR Models Generated by MLR, PLS and ANN Methods. Mini-Reviews in Medicinal Chemistry. 4(2). 167–177. 31 indexed citations
13.
Patonay, Tamás, Attila Kiss‐Szikszai, Ferenc Hollósy, et al.. (2003). Comparison of measured and calculated lipophilicity of substituted aurones and related compounds. Journal of Chromatography B. 801(2). 229–235. 22 indexed citations
14.
Erös, Dániel, et al.. (2002). Reliability of logP Predictions Based on Calculated Molecular Descriptors: A Critical Review. Current Medicinal Chemistry. 9(20). 1819–1829. 73 indexed citations
15.
Hollósy, Ferenc, Tamás Lóránd, László Őrfi, et al.. (2002). Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test. Journal of Chromatography B. 768(2). 361–368. 33 indexed citations
16.
Hollósy, Ferenc, János Seprődi, László Őrfi, et al.. (2002). Evaluation of lipophilicity and antitumour activity of parallel carboxamide libraries. Journal of Chromatography B. 780(2). 355–363. 24 indexed citations
17.
Hollósy, Ferenc, Tamás Lóránd, László Őrfi, et al.. (2002). EVALUATION OF HYDROPHOBICITY AND ANTITUMOR ACTIVITY OF A MOLECULE LIBRARY OF MANNICH KETONES OF CYCLOALKANONES. Journal of Liquid Chromatography & Related Technologies. 25(7). 1129–1143. 7 indexed citations
18.
Páska, Csilla, László Őrfi, István Kövesdi, et al.. (1999). [Biological activity and structure of antitumor compounds from Plantago media L].. PubMed. 69(5). 232–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ákos Tarcsay Breakdown of academic impact, for papers by Ky-Youb Nam Breakdown of academic impact, for papers by Hayarpi Torosyan Breakdown of academic impact, for papers by Inge Thøger Christensen Breakdown of academic impact, for papers by Laura Maccari Breakdown of academic impact, for papers by Hitomi Yuki Breakdown of academic impact, for papers by Narayanan Surendran Breakdown of academic impact, for papers by Andy Vinter Breakdown of academic impact, for papers by Alessandro Padova Breakdown of academic impact, for papers by Kenneth A. Koeplinger
Rankless by CCL
2026